Submitted by Anonymous (not verified) on 24 March 2026 - 16:35
Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Date of authorisation: 22/05/2014, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Date of authorisation: 22/05/2014, Revision: 15, Status: Authorised